CCTST | Center for Clinical & Translational Science & Training


Main menu

Slides Available from CCTST Grand Rounds March 24

Slides are now available from the March 24 CCTST Grand Rounds.

Andrew Mulberg, MD, Vice President of Global Regulatory Affairs for Amicus Therapeutics, discussed FDA from a Former FDAer: Secrets and insights into regulatory review and drug development, especially as they relate to precision medicine and rare diseases.  Mulberg is a former deputy director of the FDA.


Mulberg also spoke on First in Human Trials and Safety Assessment for Rare and Orphan Diseases at the March 23-24 conference Ethics of Integrating Research and Clinical Care at Cincinnati Children's.